Mutant glycosyltransferases assist in the development of a targeted drug delivery system and contrast agents for MRI

Mukherjee S, Ghosh RN, Maxfield FR. Endocytosis.Physiol Rev. 1997;77:759–803. Gao H, Shi W, Freund LB. Mechanics of receptor-mediated endocytosis.Proc Natl Acad Sci USA. 2005;102:9469–9474. Bao G, Bao XR. Shedding light on the dynamics of endocytosis and viral budding.Proc Natl Acad Sci USA. 2005;102:9997–9998. Vyas SP, Singh A, Sihorkar V. Ligand-receptor-mediated drug delivery: an emerging paradigm in cellular drug targeting.Crit Rev Ther Drug Carrier Syst. 2001;18:1–76. Russell-Jones GJ. The potential use of receptor-mediated endocytosis for oral drug delivery.Adv Drug Deliv Rev. 2001;46:59–73. Qasba PK. Involvement of sugars in protein-protein interactions.Carbohydrate Polymers. 2000;41:293–309. Bourne Y, Bolgiano B, Liao DI, et al. Crosslinking of mammalian lectin (galectin-1) by complex bi-antennary saccharides.Nat Struct Biol. 1994;1:863–870. Bourne Y, Roussel A, Frey M, Rouge P, Fontecilla-Camps JC, Cambillau C. Three-dimensional structures of complexes of Lathyrus ochrus isolectin. I with glucose and mannose: fine specificity of the monosaccharide-binding site.Proteins. 1990;8:365–376. Wright CS. Crystal structure of a wheat germ agglutinin/glycophorin-sialoglycopeptide receptor complex: structural basis for cooperative lectin-cell binding.J Biol Chem. 1992;267:14345–14352. Crocker PR, Feizi T. Carbohydrate recognition systems: functional triads in cell-cell interactions.Curr Opin Struct Biol. 1996;6:679–691. Collins BE, Paulson JC. Cell surface biology mediated by low affinity multivalent protein-glycan interactions.Curr Opin Chem Biol. 2004;8:617–625. Akama TO, Nakagawa H, Sugihara K, et al. Germ cell survival through carbohydrate-mediated interaction with Sertoli cells.Science. 2002;295:124–127. Talbot P, Shur BD, Myles DG. Cell adhesion and fertilization: steps in oocyte transport, sperm-zona pellucida interactions, and sperm-egg fusion.Biol Reprod. 2003;68:1–9. Sharon N, Ofek I. Fighting infectious diseases with inhibitors of microbial adhesion to host tissues.Crit Rev Food Sci Nutr. 2002;42:267–272. Sharon N. Carbohydrate-lectin interactions in infectious disease.Adv Exp Med Biol. 1996;408:1–8. Sacks D, Kamhawi S. Molecular aspects of parasite-vector and vector-host interactions in leishmaniasis.Annu Rev Microbiol. 2001;55:453–483. Rudd PM, Wormald MR, Stanfield RL, et al. Roles of glycosylation of cell surface receptors involved in cellular immune recognition.J Mol Biol. 1999;293:351–366. Rudd PM, Elliott T, Cresswell P, Wilson IA, Dwek RA. Glycosylation and the immune system.Science. 2001;291:2370–2376. Lowe JB. Glycan-dependent leukocyte adhesion and recruitment in inflammation.Curr Opin Cell Biol. 2003;15:531–538. Parodi AJ. Role of N-oligosaccharide endoplasmic reticulum processing reactions in glycoprotein folding and degradation.Biochem J. 2000;348:1–13. Trombetta ES, Helenius A. Lectins as chaperones in glycoprotein folding.Curr Opin Struct Biol. 1998;8:587–592. Ghosh P, Dahms NM, Kornfeld S. Mannose 6-phosphate receptors: new twists in the tale.Nat Rev Mol Cell Biol. 2003;4:202–212. Sharon N, Lis H. History of lectins: from hemagglutinins to biological recognition molecules.Glycobiology. 2004;14:53R-62R. Yang RY, Liu FT. Galectins in cell growth and apoptosis.Cell Mol Life Sci. 2003;60:267–276. Liu F, Patterson RJ, Wang JL. Intracellular functions of galectins.Biochim Biophys Acta. 2002;1572:263–273. Handel TM, Johnson Z, Crown SE, Lau EK, Sweeney M, Proudfoot AE. Regulation of protein function by glycosaminoglyacans—as exemplified by chemokines.Annu Rev Biochem. 2005;74:385–410. Schlessinger J, Lax I, Lemmon M. Regulation of growth factor activation by proteoglycans: what is the role of the low affinity receptors?.Cell. 1995;83:357–360. Yayon A, Klagsbrun M, Esko JD, Leder P, Ornitz DM. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor.Cell. 1991;64:841–848. Herr AB, Ornitz DM, Sasisekharan R, Venkataraman G, Waksman G. Heparin-induced self-association of fibroblast growth factor-2: evidence for 2 oligomerization processes.J Biol Chem. 1997;272:16382–16389. Lam K, Rao VSR, Qasba PK. Molecular modeling studies on binding of bFGF to heparin and its receptor FGFR1.J Biomol Struct Dyn. 1998;15:1009–1027. Morell AG, Gregoriadis G, Scheinberg H, Hickman J, Ashwell G. The role of sialic acid in determining the survival of glycoproteins in the circulation.J Biol Chem. 1971;246:1461–1467. Rogers JC, Kornfeld S. Hepatic uptake of proteins coupled to fetuin glycopeptide.Biochem Biophys Res Commun. 1971;45:622–629. Lee YC, Townsend RR, Hardy MR, et al. Binding of synthetic oligosaccharides to the hepatic Gal/GalNAc lectin: dependence on fine structural features.J Biol Chem. 1983;258:199–202. Hangeland JJ, Levis JT, Lee YC, Tso POP. Cell-type specific and ligand specific enhancement of cellular uptake of oligodeoxynucleoside methylphosphonates covalently linked with a neoglycopeptide, YEE(ah-GalNAc).Bioconjug Chem. 1995;6:695–701. Weigel PH, Yik JH. Glycans as endocytosis signals: the cases of the asialoglycoprotein and hyaluronan/chondroitin sulfate receptors.Biochim Biophys Acta. 2002;1572:341–363. Roseman S. Reflections on glycobiology.J Biol Chem. 2001;276:41527–41542. Amado M, Almeida R, Schwientek T, Clausen H. Identification and characterization of large galactosyltransferase gene families: galactosyltransferases for all functions.Biochim Biophys Acta. 1999;1473:35–53. Hennet T. The galactosyltransferase family.Cell Mol Life Sci. 2002;59:1081–1095. Berger EG, Rohrer J. Galactosyltransferase: still up and running.Biochimie. 2003;85:261–274. Javaud C, Dupuy F, Maftah A, Julien R, Petit JM. The fucosyltransferase gene family: an amazing summary of the underlying mechanisms of gene evolution.Genetica. 2003;118:157–170. Harduin-Lepers A, Vallejo-Ruiz V, Krzewinski-Recchi MA, Samyn-Petit B, Julien S, Delannoy P. The human sialyltransferase family.Biochimie. 2001;83:727–737. Ten Hagen KG, Fritz TA, Tabak LA. All in the family: the UDP-GalNAc: polypeptide N-acetylgalactosaminyltransferases.Glycobiology. 2003;13:1R-16R. Wilson IB. The never-ending story of peptide O-xylosyltransferase.Cell Mol Life Sci. 2004;61:794–809. Palcic MM, Seto NO, Hindsgaul O. Natural and recombinant A and B gene encoded glycosyltransferases.Transfus Med. 2001;11:315–323. Shur BD, Evans S, Lu Q. Cell surface galactosyltransferase: current issues.Glycoconj J. 1998;15:537–548. Rodeheffer C, Shur BD. Targeted mutations in β 1,4-galactosyltransferase I reveal its multiple cellular functions.Biochim Biophys Acta. 2002;1573:258–270. Haltiwanger RS, Stanley P. Modulation of receptor signaling by glycosylation: fringe is an O-fucose-beta,3-N-acetylglucosam inyltransferase.Biochim Biophys Acta. 2002;1573:328–335. Nakamura Y, Haines N, Chen J, et al. Identification of a Drosophila gene encoding xylosylprotein beta4-galactosyltransferase that is essential for the synthesis of glycosaminoglycans and for morphogenesis.J Biol Chem. 2002;277:46280–46288. Takahashi M, Tsuda T, Ikeda Y, Honke K, Taniguchi N. Role of N-glycans in growth factor signaling.Glycoconj J. 2004;20:207–212. Feizi T. Demonstration by monoclonal antibodies that carbohydrate structures of glycoproteins and glycolipids are onco-developmental antigens.Nature. 1985;314:53–57. Hakomori S. Glycosylation defining cancer malignancy: new wine in an old bottle.Proc Natl Acad Sci USA. 2002;99:10231–10233. Couldrey C, Green JE. Metastases: the glycan connection.Breast Cancer Res. 2000;2:321–323. Freeze HH, Aebi M. Altered glycan structures: the molecular basis of congenital disorders of glycosylation.Curr Opin Struct Biol. 2005;15:490–498. Bourne Y, Henrissat B. Glycoside hydrolases and glycosyltransferases: families and functional modules.Curr Opin Struct Biol. 2001;11:593–600. Qasba PK, Ramakrishnan B, Boeggeman E. Substrate-induced conformational changes in glycosyltransferases.Trends Biochem Sci. 2005;30:53–62. Ramakrishnan B, Boeggeman E, Ramasamy V, Qasba PK. Structure and catalytic cycle beta-1,4-galactosyltransferase.Curr Opin Struct Biol. 2004;14:593–600. Ramakrishnan B, Qasba PK. Structure-based design of beta-1,4-galactosyl-transferase-I (beta 4Gal-T1) with equally efficient N-acetylgalactosaminyltransferase activity.J Biol Chem. 2002;277: 20833–20840. Pedersen LC, Darden TA, Negishi M. Crystal structure of beta 1,3-glucuronyltransferase I in complex with active donor substrate UDP-GlcUA.J Biol Chem. 2002;277:21869–21873. Kakuda S, Shiba T, Ishiguro M, et al. Structural basis for acceptor substrate recognition of a human glucuronyltransferase, GlcAT-P, an enzyme critical in the biosynthesis of the carbohydrate epitope HNK-1.J Biol Chem. 2004;279:22693–22703. Ouzzine M, Gulberti S, Levoin N, Netter P, Magdalon J, Fournel-Gigleux S. The donor substrate specificity of the human beta 1,3-glucuronosyltransferase I toward UDP-glucuronic acid is determined by two crucial histidine and arginine residues.J Biol Chem. 2002;277:25439–25445. Marcus SL, Polakowski R, Seto NO, et al. A single point mutation reverses the donor specificity of human blood group B-synthesizing galactosyltransferase.J Biol Chem. 2003;278:12403–12405. Ramakrishnan B, Boeggeman E, Qasba PK. Mutation of Arg 228 to lysine enhances the glucosyltransferase activity of bovine beta-1,4-galactosyltransferase I.Biochemistry. 2005;44:3202–3210. Khidekel N, Arndt S, Lamarre-Vincent N, et al. A chemoenzymatic approach toward the rapid and sensitive detection ofO-glcNAc posttranslational modifications.J Am Chem Soc. 2003;125:16162–16163. Mizanur RM, Jaipuri FA, Pohl NL. One-step synthesis of labeled sugar nucleotides for proteinO-GlcNAc modification studies by chemical function analysis of an archaeal protein.J Am Chem Soc. 2005;127:836–837.